Kevin P. Starr, Director, 10% Owner at Sage Therapeutics, Inc. (SAGE), sold 850,000 shares at $31.25 ($26.6M) on 2016-05-16, disclosed to the SEC on 2016-05-18.
Open-market sale of $26.6M SAGE by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| FULC | BUY | 2019-07-22 | $1.3M | — | Filing → |
| SAGE | SELL | 2018-04-19 | $10.0M | — | Filing → |
| MYOK | SELL | 2018-01-05 | $34.3M | — | Filing → |